Validation and refinement of survival models for liver retransplantation
暂无分享,去创建一个
Peter Neuhaus | Nigel Heaton | Valentin Cuervas-Mons | Atif Zaman | Roger Williams | N. Heaton | W. Bechstein | P. Neuhaus | J. O'grady | V. Cuervas-Mons | A. Zaman | P. Muiesan | R. Strong | B. Chan | O. Guckelberger | Hugo R Rosen | Joaquin Berenguer | H. Rosen | Wolf O Bechstein | Roger Williams | M. Prieto | Russell W Strong | Martin Prieto | Teresa Casanovas-Taltavull | Olaf Guckelberger | Paolo Muiesan | John O'grady | Benjamin Chan | J. Berenguer | T. Casanovas-Taltavull
[1] J. Rabkin,et al. Retransplantation for hepatic allograft failure: Prognostic modeling and ethical considerations , 2002, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[2] L. Forman,et al. Predicting the prognosis of chronic liver disease: An evolution from child to MELD , 2001, Hepatology.
[3] J. Mir,et al. Natural history of clinically compensated hepatitis C virus–related graft cirrhosis after liver transplantation , 2000, Hepatology.
[4] P. Neuhaus,et al. Normalised intrinsic mortality risk in liver transplantation: European Liver Transplant Registry study , 2000, The Lancet.
[5] J. Devlin,et al. Clinical characteristics affecting the outcome of liver retransplantation. , 1997, Transplantation.
[6] H. Rosen. Disease recurrence following liver transplantation. , 2000, Clinics in liver disease.
[7] L. Ferrell,et al. HCV-related fibrosis progression following liver transplantation: increase in recent years. , 2000, Journal of hepatology.
[8] P. Grambsch,et al. Primary sclerosing cholangitis: refinement and validation of survival models. , 1992, Gastroenterology.
[9] D.,et al. Regression Models and Life-Tables , 2022 .
[10] Prioritization of patients with liver cancer within the MELD system , 2002, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[11] G. Klintmalm,et al. A simple model to estimate survival after retransplantation of the liver. , 1999, Transplantation.
[12] R M Arnold,et al. Rationing failure. The ethical lessons of the retransplantation of scarce vital organs. , 1993, JAMA.
[13] T. Therneau,et al. A model to predict survival in patients with end‐stage liver disease , 2001 .
[14] E. Keeffe,et al. Liver transplantation: current status and novel approaches to liver replacement. , 2001, Gastroenterology.
[15] G. Everson. MELD: the answer or just more questions? , 2003, Gastroenterology.
[16] A. Bhalla,et al. Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. , 1997, Gastroenterology.
[17] Mark J. Thomas,et al. A correlation between the pretransplantation MELD score and mortality in the first two years after liver transplantation , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[18] J. Hanley,et al. The meaning and use of the area under a receiver operating characteristic (ROC) curve. , 1982, Radiology.
[19] Paul L. Martin,et al. A model to predict survival following liver retransplantation , 1999, Hepatology.
[20] T. Therneau,et al. Hepatic retransplantation in cholestatic liver disease: Impact of the interval to retransplantation on survival and resource utilization , 1999, Hepatology.
[21] M McCarthy,et al. Hepatology , 1999, Rapid Medicine.
[22] D. Samuel,et al. Decision for Retransplantation of the Liver: An Experience- and Cost-Based Analysis , 2002, Annals of surgery.
[23] J. Mir,et al. Severe recurrent hepatitis C after liver retransplantation for hepatitis C virus–related graft cirrhosis , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[24] S. Hubscher,et al. Histologic and biochemical changes during the evolution of chronic rejection of liver allografts , 2002, Hepatology.
[25] D. Manninen,et al. Is retransplantation cost effective? , 1993, Transplantation proceedings.
[26] J. Emond,et al. Model for end‐stage liver disease and Child‐Turcotte‐Pugh score as predictors of pretransplantation disease severity, posttransplantation outcome, and resource utilization in United Network for Organ Sharing status 2A patients , 2002, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[27] J. Pinto-Martin,et al. The relation of transient hypothyroxinemia in preterm infants to neurologic development at two years of age. , 1996, The New England journal of medicine.
[28] T. Starzl,et al. Hepatic Retransplantation--an analysis of risk factors associated with outcome. , 1996, Transplantation.
[29] A. Chui,et al. Pancreatitis in adult orthotopic liver allograft recipients: Risk factors and outcome , 2000, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.